Abbott's Omnilink Elite Vascular Balloon-Expandable Stent System Receives FDA Approval
Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite^® Vascular Balloon-Expandable Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) that affects the lower extremities. Iliac artery disease can progress to where patients experience chronic pain and reduced ability to walk, potentially leading to permanent disability. The FDA approval is supported by positive clinical data from the MOBILITY (Omnilink Elite or Absolute Pro^® Stent Used in the Iliac Artery) study. The MOBILITY study demonstrated that Omnilink Elite is safe and effective, including when used for patients who are difficult-to-treat due to complex disease resulting from severely calcified lesions.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.